# 61703-262-05 · Carboplatin Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker For 61703-262-05 · Carboplatin Injection · Hospira, Inc., a Pfizer Company, package ndc is 61703-262-05; generic name is Carboplatin Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-15. - **Package NDC:** 61703-262-05 _(verified: appears in the quote below)_ - **Generic name:** Carboplatin Injection _(verified: appears in the quote below)_ - **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Unavailable _(verified: appears in the quote below)_ - **FDA note:** Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay _(verified: appears in the quote below)_ - **Initial posting date:** 04/28/2023 _(verified: appears in the quote below)_ - **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 1222 _(our reading, not quoted from the source)_ - **Reason for shortage:** Other _(verified: appears in its own passage below)_ - **Dosage form:** Injection _(verified: appears in its own passage below)_ - **Therapeutic category:** Oncology _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "04/28/2023", "package_ndc": "61703-262-05", "generic_name": "Carboplatin Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current" ### Status > "update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current" ### Last update date > "update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current" ### Reason for shortage > "update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current" ### Dosage form > "update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current" ### Therapeutic category > "update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-15. Review by: 2026-09-18. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).